Cases & Deals

Celgene obtains dismissal in Washington product liability action

Clients Celgene Corporation

Jones Day, on behalf of Celgene Corporation, obtained a dismissal of a product liability suit against a host of drug and medical device manufacturers stemming from alleged heparin-induced thrombocytopenia or "HIT".

McFarland v. APP Pharmaceuticals, LLC, et al., Case No. 2:10-CV-01746 (W.D. Wash.)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.